Xiangyu Historical Income Statement

688626 Stock

35.98 0.64 1.75%

Historical analysis of Xiangyu Medical income statement accounts such as Net Interest Income of 21.5 M, Interest Income of 20.2 M or Interest Expense of 1.3 M can show how well Xiangyu Medical Co performed in making a profits. Evaluating Xiangyu Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Xiangyu Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Xiangyu Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xiangyu Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiangyu Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Xiangyu Income Statement Analysis

Xiangyu Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Xiangyu Medical shareholders. The income statement also shows Xiangyu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Xiangyu Medical Income Statement Chart

The current year's Tax Provision is expected to grow to about 15 M, whereas Net Interest Income is forecasted to decline to about 21.5 M.

Tax Provision Selling General Administrative Total Revenue Gross Profit

Add Fundamental

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Xiangyu Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Xiangyu Medical Co minus its cost of goods sold. It is profit before Xiangyu Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Xiangyu Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Xiangyu Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiangyu Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 15 M, whereas Net Interest Income is forecasted to decline to about 21.5 M.

	2022	2023	2024	2025 (projected)
Net Interest Income	26.6M	29.8M	34.3M	21.5M
Tax Provision	9.7M	15.7M	14.1M	15.0M

Net Interest Income Tax Provision

Xiangyu Medical income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Net Income	Minority Interest
Tax Provision		-0.41	-0.42	0.0	-0.46	-0.34	-0.32	0.21	0.01	-0.53	-0.19	-0.38	-0.53	-0.57	0.08	0.01	0.12
Net Interest Income	-0.41		1.0	-0.76	-0.31	0.88	0.88	0.64	0.83	0.97	0.95	0.88	0.9	0.94	0.79	0.83	0.0
Interest Income	-0.42	1.0		-0.72	-0.26	0.91	0.91	0.67	0.85	0.98	0.94	0.91	0.92	0.96	0.81	0.85	-0.06
Interest Expense	0.0	-0.76	-0.72		0.83	-0.46	-0.47	-0.45	-0.6	-0.62	-0.88	-0.45	-0.43	-0.55	-0.59	-0.61	-0.38
Selling General Administrative	-0.46	-0.31	-0.26	0.83		0.0	-0.01	-0.22	-0.27	-0.12	-0.52	0.03	0.09	-0.04	-0.3	-0.28	-0.53
Total Revenue	-0.34	0.88	0.91	-0.46	0.0		1.0	0.84	0.93	0.93	0.82	1.0	0.98	0.94	0.9	0.92	-0.42
Gross Profit	-0.32	0.88	0.91	-0.47	-0.01	1.0		0.85	0.93	0.93	0.83	1.0	0.97	0.93	0.91	0.93	-0.42
Operating Income	0.21	0.64	0.67	-0.45	-0.22	0.84	0.85		0.96	0.64	0.72	0.82	0.7	0.63	0.97	0.96	-0.46
Net Income From Continuing Ops	0.01	0.83	0.85	-0.6	-0.27	0.93	0.93	0.96		0.81	0.86	0.91	0.83	0.79	1.0	1.0	-0.34
Research Development	-0.53	0.97	0.98	-0.62	-0.12	0.93	0.93	0.64	0.81		0.89	0.94	0.97	0.99	0.77	0.81	-0.16
Ebitda	-0.19	0.95	0.94	-0.88	-0.52	0.82	0.83	0.72	0.86	0.89		0.81	0.79	0.86	0.85	0.87	0.03
Cost Of Revenue	-0.38	0.88	0.91	-0.45	0.03	1.0	1.0	0.82	0.91	0.94	0.81		0.98	0.95	0.88	0.91	-0.43
Total Operating Expenses	-0.53	0.9	0.92	-0.43	0.09	0.98	0.97	0.7	0.83	0.97	0.79	0.98		0.98	0.79	0.83	-0.37
Reconciled Depreciation	-0.57	0.94	0.96	-0.55	-0.04	0.94	0.93	0.63	0.79	0.99	0.86	0.95	0.98		0.75	0.79	-0.25
Income Before Tax	0.08	0.79	0.81	-0.59	-0.3	0.9	0.91	0.97	1.0	0.77	0.85	0.88	0.79	0.75		1.0	-0.34
Net Income	0.01	0.83	0.85	-0.61	-0.28	0.92	0.93	0.96	1.0	0.81	0.87	0.91	0.83	0.79	1.0		-0.32
Minority Interest	0.12	0.0	-0.06	-0.38	-0.53	-0.42	-0.42	-0.46	-0.34	-0.16	0.03	-0.43	-0.37	-0.25	-0.34	-0.32

Click cells to compare fundamentals

Xiangyu Medical Account Relationship Matchups

Xiangyu Medical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Tax Provision	26.8M	23.2M	9.7M	15.7M	14.1M	15.0M
Net Interest Income	12.5M	24.0M	26.6M	29.8M	34.3M	21.5M
Interest Income	11.6M	21.6M	23.9M	29.5M	34.0M	20.2M
Interest Expense	172.3K	0.0	189.6K	2.8M	2.5M	1.3M
Selling General Administrative	45.5M	59.7M	78.0M	101.4M	116.6M	85.9M
Total Revenue	495.5M	523.5M	488.5M	744.8M	856.5M	589.5M
Gross Profit	335.7M	357.2M	323.8M	511.1M	587.8M	398.5M
Operating Income	214.7M	193.0M	101.3M	220.6M	253.7M	192.3M
Net Income From Continuing Ops	196.0M	199.5M	123.3M	228.3M	262.6M	192.7M
Research Development	51.6M	68.6M	92.4M	106.7M	122.8M	79.4M
Cost Of Revenue	159.8M	166.3M	164.8M	233.7M	268.8M	191.0M
Total Operating Expenses	280.8M	330.5M	387.2M	524.2M	602.9M	397.2M
Reconciled Depreciation	10.8M	11.4M	16.1M	18.1M	20.8M	14.5M
Income Before Tax	222.8M	222.7M	133.0M	244.0M	280.6M	213.4M
Net Income	196.3M	201.9M	125.5M	227.1M	261.2M	193.5M
Minority Interest	252.8K	2.4M	2.2M	(1.2M)	(1.1M)	(1.0M)

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

Other Information on Investing in Xiangyu Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xiangyu Historical Income Statement

About Xiangyu Income Statement Analysis

Xiangyu Medical Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

Xiangyu Medical income statement Correlations

Xiangyu Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Xiangyu Medical income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Xiangyu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	+ 1.0	Net Interest Income
Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Gross Profit
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops

Ebitda	- 0.88	Interest Expense
Interest Expense	- 0.76	Net Interest Income
Interest Expense	- 0.72	Interest Income
Research Development	- 0.62	Interest Expense
Net Income	- 0.61	Interest Expense
Net Income From Continuing Ops	- 0.6	Interest Expense